Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 675 of 3173 entries
View as:

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02201524 Org: User:
Start: 11/30/14 End: 09/30/15 Due: 09/30/16

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04664153 Org: User:
Start: 12/21/20 End: 08/18/21 Due: 08/18/22

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02197130 Org: User:
Start: 09/30/14 End: 10/31/16 Due: 10/31/17

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Phase: N/A Priority: Normal
NCT ID: NCT04543188 Org: User:
Start: 01/08/21 End: 03/20/24 Due: 03/20/25

Voxelotor Neurocognitive Function Study

Phase: N/A Priority: Normal
NCT ID: NCT05228834 Org: User:
Start: 06/24/22 End: 09/30/22 Due: 09/30/23

A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01537497 Org: User:
Start: 03/31/12 End: 05/31/12 Due: 05/31/13

Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort

Phase: N/A Priority: Normal
NCT ID: NCT00824850 Org: User:
Start: 01/31/10 End: 09/30/10 Due: 09/30/11

Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries

Phase: N/A Priority: Normal
NCT ID: NCT04669366 Org: User:
Start: 01/20/21 End: 03/18/22 Due: 03/18/23

Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis

Phase: N/A Priority: Normal
NCT ID: NCT00680134 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01163253 Org: User:
Start: 09/30/10 End: 06/30/16 Due: 06/30/17

Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04360187 Org: User:
Start: 07/27/20 End: 09/08/21 Due: 09/08/22

Study for Evaluating Different Methods of Measuring Depression Treatment Response

Phase: N/A Priority: Normal
NCT ID: NCT00406952 Org: User:
Start: 11/30/06 End: 08/31/07 Due: 08/31/08

Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01405118 Org: User:
Start: 06/30/11 End: 07/31/11 Due: 07/31/12

A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01100307 Org: User:
Start: 05/31/10 End: 08/31/12 Due: 08/31/13

A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02316756 Org: User:
Start: 12/31/14 End: 03/31/15 Due: 03/31/16

Varenicline Pregnancy Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT01290445 Org: User:
Start: 09/13/07 End: 05/01/16 Due: 05/01/17

Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole

Phase: N/A Priority: Normal
NCT ID: NCT04735367 Org: User:
Start: 02/03/21 End: 09/29/23 Due: 09/29/24

Study Evaluating Severe Surgical Site Infections (SSIs) Following Contaminated Or Dirty-infected Abdominal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00906074 Org: User:
Start: 02/28/09 End: 11/30/10 Due: 11/30/11

A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060

Phase: N/A Priority: Normal
NCT ID: NCT06897683 Org: User:
Start: 03/21/25 End: 07/14/25 Due: 07/14/26

Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04863417 Org: User:
Start: 06/30/21 End: 09/09/21 Due: 09/09/22

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Phase: N/A Priority: Normal
NCT ID: NCT04804033 Org: User:
Start: 03/26/21 End: 03/21/24 Due: 03/21/25

Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00195260 Org: User:
Start: 10/31/04 End: 11/30/07 Due: 11/30/08

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Phase: N/A Priority: Normal
NCT ID: NCT00139685 Org: User:
Start: 04/30/98 End: 07/31/07 Due: 07/31/08

A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT06476665 Org: User:
Start: 11/07/24 End: 06/22/29 Due: 06/22/30

Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT00544557 Org: User:
Start: 10/31/07 End: 05/31/14 Due: 05/31/15